Related Experiment Videos
Enantiomeric drug development: issues, considerations, and regulatory requirements
N R Srinivas1, R H Barbhaiya, K K Midha
1Metabolism and Pharmacokinetics, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543, USA.
Journal of Pharmaceutical Sciences
|December 18, 2001
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Quantitation of VEGFR2 (vascular endothelial growth factor receptor) inhibitors--review of assay methodologies and perspectives.
Biomedical chromatography : BMC·2014
Experimental and computational study of pMDI aerosol delivery in mucus-coated pediatric airways: Effects of inhalation flow and actuation timing.
Journal of pharmaceutical sciences·2026
Biophysical investigations into the impact of crystallization conditions on monoclonal antibody properties and purification.
Journal of pharmaceutical sciences·2026
Implementing scientifically sound practices during drug development: An industry perspective from analytical development.
Journal of pharmaceutical sciences·2026
Block the bitter: Microencapsulation of zidovudine as a taste masking technique for drug inclusion into an oral thin film.
Journal of pharmaceutical sciences·2026
Utilization patterns of second-generation androgen receptor pathway inhibitors as first-line therapy for prostate cancer in the United States.
Prostate cancer and prostatic diseases·2026
Clinical Approach to Impulse Control-Related Behavioral Disorders in Parkinson's Disease: A Scoping Review.
Movement disorders clinical practice·2026
Researchers struggle to improve nonopioid pain drugs.
Science (New York, N.Y.)·2026